Swaminathan Sethuraman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Swaminathan Sethuraman has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
Uma Maheswari Krishnan
27 shared publications- Anuradha Subramanian
Tissue Engineering & Additive Manufacturing (TEAM) Lab, Centre for Nanotechnology & Advanced Biomaterials, ABCDE Innovation Centre, School of Chemical & Biotechnology, SASTRA Deemed University, Thanjavur, 613401, India
26 shared publications - Dhakshinamoorthy Sundaramurthi
Tissue Engineering & Additive Manufacturing (TEAM) Lab, Centre for Nanotechnology & Advanced Biomaterials, ABCDE Innovation Centre, School of Chemical & Biotechnology, SASTRA Deemed University, India
12 shared publications - Uma Maheswari Krishnan
Centre for Nanotechnology & Advanced Biomaterials (CeNTAB), School of Chemical & Biotechnology, SASTRA Deemed University, Thanjavur 613 401, Tamil Nadu, India
8 shared publications Dhakshinamoorthy Sundaramurthi
Tissue Engineering & Additive Manufacturing (TEAM) Lab, Centre for Nanotechnology & Advanced Biomaterials (CeNTAB), ABCDE Innovation Centre, School of Chemical & Biotechnology (SCBT), SASTRA Deemed University, Tirumalaisamudram, Thanjavur, India
5 shared publications- Harshavardhan Budharaju
School of Chemical, Materials and Biological Engineering, University of Sheffield, Mappin Street, Sheffield S1 3JD, U.K.
5 shared publications
Latest Publications
- 13 October 2026
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 14 (20) , 5330-5358
Next-generation hydrogels and strategies to recreate 3D tumour microenvironments for osteosarcoma: from bioprinting to therapeutic testing
Hydrogel based in vitro models and adjuvant therapies for osteosarcoma. The image is modified from Servier Medical Art (https://smart.servier.com), licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/).
- 13 October 2026
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 14 (20) , 5330-5358
Next-generation hydrogels and strategies to recreate 3D tumour microenvironments for osteosarcoma: from bioprinting to therapeutic testing
Hydrogel based in vitro models and adjuvant therapies for osteosarcoma. The image is modified from Servier Medical Art (https://smart.servier.com), licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/).
- 6 July 2026
- Published by Springer Nature in In vitro models
- Vol. 5 (4) , 659-674
Development of a low viscosity PEGDA - gelatin bioink for embedded bioprinting of complex structures and lung adenocarcinoma (LUAD) model
- 6 July 2026
- Published by Springer Nature in In vitro models
- Vol. 5 (4) , 659-674
Development of a low viscosity PEGDA - gelatin bioink for embedded bioprinting of complex structures and lung adenocarcinoma (LUAD) model
- 30 April 2026
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 14 (22) , 7013-7033
Fabrication of a hybrid cellularized cardiac patch via 3D bioprinting of alginate-gelatin-PEOz patterns on electrospun PLCL-PEOz nanofibers
Integrating electrospinning & 3D bioprinting to biofabricate 3D cellular cardiac patches with topographical and cellular cues for improved cardiac regeneration.
- 30 April 2026
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 14 (22) , 7013-7033
Fabrication of a hybrid cellularized cardiac patch via 3D bioprinting of alginate-gelatin-PEOz patterns on electrospun PLCL-PEOz nanofibers
Integrating electrospinning & 3D bioprinting to biofabricate 3D cellular cardiac patches with topographical and cellular cues for improved cardiac regeneration.
- 16 March 2026
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 12 (4) , 1913-1946
Advances in 3D Bioprinting of Functional Skeletal Muscle Constructs: Focus on Preclinical Models and Evaluation Strategies
Skeletal muscle is an important organ system of the human body, which is responsible for maintaining body posture and movement and also plays an essential role in metabolic and endocrine functions. Although skeletal muscle has intrinsic regeneration ability, loss exceeding approximately 20% of the mass or volume of an individual muscle is considered volumetric muscle loss (VML), which requires surgical intervention for repair. Tissue engineered scaffolds prepared using techniques such as electrospinning, hydrogel casting, particulate leaching, freeze-drying, freeze-thawing, and bioprinting are promising for treating VML injuries. In this review, we discuss various extrusion-based bioprinting strategies to fabricate skeletal muscle constructs aimed at treating VML. Further, this review provides a comprehensive overview of various extrusion-based bioprinting techniques to fabricate muscle tissues such as support-based, co-axial, in situ, cryobioprinting, spheroids, and 4D bioprinting. Different bioink systems, their key properties, and similarities with the native extracellular matrix (ECM) are elaborated. In addition, commonly used preclinical models for assessing the efficacy of skeletal muscle constructs, as well as various experimental methods for assessing functional recovery after VML injuries treated with engineered tissue constructs, are discussed. The limitations of current approaches in the successful fabrication of skeletal muscle constructs using bioprinting techniques are highlighted. Finally, the future scope in the development of more efficient experimental tools to assess the in vivo efficacy of bioprinted constructs to treat VML are discussed.
- 16 March 2026
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 12 (4) , 1913-1946
Advances in 3D Bioprinting of Functional Skeletal Muscle Constructs: Focus on Preclinical Models and Evaluation Strategies
Skeletal muscle is an important organ system of the human body, which is responsible for maintaining body posture and movement and also plays an essential role in metabolic and endocrine functions. Although skeletal muscle has intrinsic regeneration ability, loss exceeding approximately 20% of the mass or volume of an individual muscle is considered volumetric muscle loss (VML), which requires surgical intervention for repair. Tissue engineered scaffolds prepared using techniques such as electrospinning, hydrogel casting, particulate leaching, freeze-drying, freeze-thawing, and bioprinting are promising for treating VML injuries. In this review, we discuss various extrusion-based bioprinting strategies to fabricate skeletal muscle constructs aimed at treating VML. Further, this review provides a comprehensive overview of various extrusion-based bioprinting techniques to fabricate muscle tissues such as support-based, co-axial, in situ, cryobioprinting, spheroids, and 4D bioprinting. Different bioink systems, their key properties, and similarities with the native extracellular matrix (ECM) are elaborated. In addition, commonly used preclinical models for assessing the efficacy of skeletal muscle constructs, as well as various experimental methods for assessing functional recovery after VML injuries treated with engineered tissue constructs, are discussed. The limitations of current approaches in the successful fabrication of skeletal muscle constructs using bioprinting techniques are highlighted. Finally, the future scope in the development of more efficient experimental tools to assess the in vivo efficacy of bioprinted constructs to treat VML are discussed.
- Open Access
- 12 January 2026
- Published by Springer Nature in BMC Methods
- Vol. 3 (1) , 2
Srishti: a custom-built laser-assisted 3D bioprinter for fabricating high-resolution biological constructs
- 12 January 2026
- Published by Springer Nature in BMC Methods
- Vol. 3 (1) , 2
Open AccessSrishti: a custom-built laser-assisted 3D bioprinter for fabricating high-resolution biological constructs
- 2 July 2025
- Published by Elsevier in Carbohydrate Polymers
- Vol. 367, 123993
Protein–in–polysaccharide bioink for 3D bioprinting of muscle mimetic tissue constructs to treat volumetric muscle loss
- 2 July 2025
- Published by Elsevier in Carbohydrate Polymers
- Vol. 367, 123993
Protein–in–polysaccharide bioink for 3D bioprinting of muscle mimetic tissue constructs to treat volumetric muscle loss
- Open Access
- 13 January 2025
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 36 (1) , 1-13
Insights on the role of cryoprotectants in enhancing the properties of bioinks required for cryobioprinting of biological constructs
Preservation and long-term storage of readily available cell-laden tissue-engineered products are major challenges in expanding their applications in healthcare. In recent years, there has been increasing interest in the development of off-the-shelf tissue-engineered products using the cryobioprinting approach. Here, bioinks are incorporated with cryoprotective agents (CPAs) to allow the fabrication of cryopreservable tissue constructs. Although this method has shown potential in the fabrication of cryopreservable tissue-engineered products, the impact of the CPAs on the viscoelastic behavior and printability of the bioinks at cryo conditions remains unexplored. In this study, we have evaluated the influence of CPAs such as glycerol and dimethyl sulfoxide (DMSO) on the rheological properties of pre-crosslinked alginate bioinks for cryoprinting applications. DMSO-incorporated bioinks showed a reduction in viscosity and yield stress, while the addition of glycerol improved both the properties due to interactions with the calcium chloride used for pre-crosslinking. Further, tube inversion and printability experiments were performed to identify suitable concentrations and cryobioprinting conditions for bioinks containing CPAs & pre-crosslinked with CaCl2. Finally, based on the printability analysis & cell recovery results, 10% glycerol was used for cryobioprinting and preservation of cell-laden constructs at −80 °C and the viability of cells within the printed structures were evaluated after recovery. Cell viability results indicate that the addition of 10% glycerol to the pre-crosslinked bioink significantly improved cell viability compared to bioinks without CPAs, confirming the suitability of the developed bioink combination to fabricate tissue constructs for on-demand applications. Graphical abstract Effect of cryoprotectants on the viscoelastic behavior of bioinks and cell recovery in cryobioprinted tissue constructs.
- 13 January 2025
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 36 (1) , 1-13
Open AccessInsights on the role of cryoprotectants in enhancing the properties of bioinks required for cryobioprinting of biological constructs
Preservation and long-term storage of readily available cell-laden tissue-engineered products are major challenges in expanding their applications in healthcare. In recent years, there has been increasing interest in the development of off-the-shelf tissue-engineered products using the cryobioprinting approach. Here, bioinks are incorporated with cryoprotective agents (CPAs) to allow the fabrication of cryopreservable tissue constructs. Although this method has shown potential in the fabrication of cryopreservable tissue-engineered products, the impact of the CPAs on the viscoelastic behavior and printability of the bioinks at cryo conditions remains unexplored. In this study, we have evaluated the influence of CPAs such as glycerol and dimethyl sulfoxide (DMSO) on the rheological properties of pre-crosslinked alginate bioinks for cryoprinting applications. DMSO-incorporated bioinks showed a reduction in viscosity and yield stress, while the addition of glycerol improved both the properties due to interactions with the calcium chloride used for pre-crosslinking. Further, tube inversion and printability experiments were performed to identify suitable concentrations and cryobioprinting conditions for bioinks containing CPAs & pre-crosslinked with CaCl2. Finally, based on the printability analysis & cell recovery results, 10% glycerol was used for cryobioprinting and preservation of cell-laden constructs at −80 °C and the viability of cells within the printed structures were evaluated after recovery. Cell viability results indicate that the addition of 10% glycerol to the pre-crosslinked bioink significantly improved cell viability compared to bioinks without CPAs, confirming the suitability of the developed bioink combination to fabricate tissue constructs for on-demand applications. Graphical abstract Effect of cryoprotectants on the viscoelastic behavior of bioinks and cell recovery in cryobioprinted tissue constructs.
- 30 September 2024
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 7 (10) , 6706-6719
Fabrication of Anatomically Equivalent Pectin-Based Multifilament Nerve Conduits
Reuniting denuded nerve ends after a long segmental peripheral nerve defect is challenging due to delayed axonal regeneration and incomplete, nonspecific reinnervation, as conventional hollow nerve guides fail to ensure proper fascicular complementation and obstruct axonal guidance across the defects. This study focuses on fabricating multifilament conduits using a plant-derived anionic polysaccharide, pectin, where the abundant availability of carboxylate (COO-) functional groups in pectin facilitates instantaneous sol-gel transition upon interaction with divalent cations. Despite their advantages, pectin hydrogels encounter structural instability under physiological conditions. Hence, pectin is conjugated with light-sensitive methacrylate residues (49.8% methacrylation) to overcome these issues, enabling the fabrication of dual cross-linked multifilament nerve conduits through an ionic interaction-driven, template-free 3D wet writing process, followed by photo-cross-linking at 525 nm. The anatomical equivalence including peri-, epi-, and endoneurium structures of the customized multifilament conduits was confirmed through scanning electron micrographs and micro-CT analysis of rat and goat sciatic nerve tissues. Furthermore, the fabricated multifilament nerve conduits demonstrated cytocompatibility and promoted the expression of neuron-specific intermediate filament protein (NF-200) in PC12 cells and neurite outgrowth of 16.90 ± 1.82 μm on day 14. Micro-CT imaging of an anastomosed native goat sciatic nerve with an 8-filament conduit demonstrated precise fascicular complementation in an ex vivo interpositional goat model. This approach not only eliminates the need for a suture-intensive ligation process but also highlights the customizability of multifilament conduits to meet patient- and injury-specific needs.
- 30 September 2024
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 7 (10) , 6706-6719
Fabrication of Anatomically Equivalent Pectin-Based Multifilament Nerve Conduits
Reuniting denuded nerve ends after a long segmental peripheral nerve defect is challenging due to delayed axonal regeneration and incomplete, nonspecific reinnervation, as conventional hollow nerve guides fail to ensure proper fascicular complementation and obstruct axonal guidance across the defects. This study focuses on fabricating multifilament conduits using a plant-derived anionic polysaccharide, pectin, where the abundant availability of carboxylate (COO-) functional groups in pectin facilitates instantaneous sol-gel transition upon interaction with divalent cations. Despite their advantages, pectin hydrogels encounter structural instability under physiological conditions. Hence, pectin is conjugated with light-sensitive methacrylate residues (49.8% methacrylation) to overcome these issues, enabling the fabrication of dual cross-linked multifilament nerve conduits through an ionic interaction-driven, template-free 3D wet writing process, followed by photo-cross-linking at 525 nm. The anatomical equivalence including peri-, epi-, and endoneurium structures of the customized multifilament conduits was confirmed through scanning electron micrographs and micro-CT analysis of rat and goat sciatic nerve tissues. Furthermore, the fabricated multifilament nerve conduits demonstrated cytocompatibility and promoted the expression of neuron-specific intermediate filament protein (NF-200) in PC12 cells and neurite outgrowth of 16.90 ± 1.82 μm on day 14. Micro-CT imaging of an anastomosed native goat sciatic nerve with an 8-filament conduit demonstrated precise fascicular complementation in an ex vivo interpositional goat model. This approach not only eliminates the need for a suture-intensive ligation process but also highlights the customizability of multifilament conduits to meet patient- and injury-specific needs.
- 23 September 2024
- Published by IOP Publishing in Biofabrication
- Vol. 16 (4) , 042008
Biofabrication & cryopreservation of tissue engineered constructs for on-demand applications
Tissue engineered constructs prepared using conventional scaffold-based approaches have the potential to repair or regenerate damaged tissues and organs. Various scaffold fabrication strategies such as electrospinning, solvent casting, particulate leaching, gas foaming, hydrogels, freeze-drying, and 3D bioprinting have been used to fabricate artificial tissues. In recent times, 3D bioprinting has been predominantly used in various biomedical fields, including healthcare and pharmaceutical applications due to precision in 3D geometry. However, there are no viable strategies to preserve bioprinted constructs for on-demand applications because of the lack of specialized techniques or cryopreservation agents to maintain the cell viability and functionality of the bioprinted tissues. To solve this issue, cryopreservation of bioprinted tissues has emerged in recent years to develop methods to create and cryopreserve bioprinted constructs for on-demand applications. This review discusses various techniques used for producing ready-to-use tissue engineered products such as electrospinning, hydrogels, 3D bioprinting, and other bioprinting approaches. Further, the factors influencing the bioprinted tissues, such as cryoprotectants, polymer types and crosslinker concentrations, crosslinking approaches, viscoelastic properties, storage facilities, etc, were also discussed in detail. The potential of cryopreservable bioprinted tissues in various healthcare applications are elaborated with lucid examples. Finally, the conclusions and possible future directions for the fabrication and cryopreservation of tissue engineered products are highlighted.
- 23 September 2024
- Published by IOP Publishing in Biofabrication
- Vol. 16 (4) , 042008
Biofabrication & cryopreservation of tissue engineered constructs for on-demand applications
Tissue engineered constructs prepared using conventional scaffold-based approaches have the potential to repair or regenerate damaged tissues and organs. Various scaffold fabrication strategies such as electrospinning, solvent casting, particulate leaching, gas foaming, hydrogels, freeze-drying, and 3D bioprinting have been used to fabricate artificial tissues. In recent times, 3D bioprinting has been predominantly used in various biomedical fields, including healthcare and pharmaceutical applications due to precision in 3D geometry. However, there are no viable strategies to preserve bioprinted constructs for on-demand applications because of the lack of specialized techniques or cryopreservation agents to maintain the cell viability and functionality of the bioprinted tissues. To solve this issue, cryopreservation of bioprinted tissues has emerged in recent years to develop methods to create and cryopreserve bioprinted constructs for on-demand applications. This review discusses various techniques used for producing ready-to-use tissue engineered products such as electrospinning, hydrogels, 3D bioprinting, and other bioprinting approaches. Further, the factors influencing the bioprinted tissues, such as cryoprotectants, polymer types and crosslinker concentrations, crosslinking approaches, viscoelastic properties, storage facilities, etc, were also discussed in detail. The potential of cryopreservable bioprinted tissues in various healthcare applications are elaborated with lucid examples. Finally, the conclusions and possible future directions for the fabrication and cryopreservation of tissue engineered products are highlighted.
- Open Access
- 29 July 2024
- Published by Elsevier in SSRN Electronic Journal
Preparation of Thermoresponsive & Enzymatically Crosslinkable Gelatin-Gellan Gum Bioink: A Protein-Polysaccharide Hydrogel for 3d Bioprinting of Complex Soft Tissues
A new combination of gelatin (GL)-gellan gum (GG) bioink was successfully formulated and demonstrated to have excellent printability and shape fidelity. Three different combinations of gelatin-gellan gum (5GL/2GG, 7.5GL/2GG and 10GL/2GG) composite bioinks were developed. Based on rheological properties, 7.5GL/2GG bioink was found optimal for extrusion 3D bioprinting. Post-bioprinting, the GL/GG constructs were enzymatically crosslinked using 10% transglutaminase (TG) for 3 h. To check the efficacy of TG crosslinking, GL/GG constructs were crosslinked with only CaCl2 (0.3 M) for 30 minutes and also dual crosslinked with CaCl2 (0.3 M) for 30 minutes followed by TG crosslinking for 2.5 h. Direct and indirect cytotoxicity assays for the developed bioink was carried out using human dermal fibroblasts (HDFa) and human adult immortalized keratinocytes (HaCaT) cell lines. It was found that the crosslinked constructs were cytocompatible and showed higher cell viability (>70 %) as per the ISO 10993-5. The 3D bioprinted GL/GG constructs crosslinked with only TG showed better cell viability, proliferation and cell spreading compared to dual crosslinked constructs. Further, 7.5GL/2GG bioink with TG crosslinking was found to be ideal for printing complex and highly intricate structures with excellent shape fidelity for regenerative medicine and drug screening applications.
- 29 July 2024
- Published by Elsevier in SSRN Electronic Journal
Open AccessPreparation of Thermoresponsive & Enzymatically Crosslinkable Gelatin-Gellan Gum Bioink: A Protein-Polysaccharide Hydrogel for 3d Bioprinting of Complex Soft Tissues
A new combination of gelatin (GL)-gellan gum (GG) bioink was successfully formulated and demonstrated to have excellent printability and shape fidelity. Three different combinations of gelatin-gellan gum (5GL/2GG, 7.5GL/2GG and 10GL/2GG) composite bioinks were developed. Based on rheological properties, 7.5GL/2GG bioink was found optimal for extrusion 3D bioprinting. Post-bioprinting, the GL/GG constructs were enzymatically crosslinked using 10% transglutaminase (TG) for 3 h. To check the efficacy of TG crosslinking, GL/GG constructs were crosslinked with only CaCl2 (0.3 M) for 30 minutes and also dual crosslinked with CaCl2 (0.3 M) for 30 minutes followed by TG crosslinking for 2.5 h. Direct and indirect cytotoxicity assays for the developed bioink was carried out using human dermal fibroblasts (HDFa) and human adult immortalized keratinocytes (HaCaT) cell lines. It was found that the crosslinked constructs were cytocompatible and showed higher cell viability (>70 %) as per the ISO 10993-5. The 3D bioprinted GL/GG constructs crosslinked with only TG showed better cell viability, proliferation and cell spreading compared to dual crosslinked constructs. Further, 7.5GL/2GG bioink with TG crosslinking was found to be ideal for printing complex and highly intricate structures with excellent shape fidelity for regenerative medicine and drug screening applications.